31 Aug Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe, Valentin Fuster, Anuradha Lala, Adam J. Russak, Benjamin S. Glicksberg, Matthew A. Levin, Alexander W. Charney, Jagat Narula, Zahi A. Fayad, Emilia Bagiella, Shan Zhao and Girish N. Nadkarni
ABSTRACT
The novel coronavirus disease-2019 (COVID-19) has affected almost all countries in the world. There are reports of an increase in thromboembolic events among hospitalized patients, and there are anecdotal observations of improved outcomes with systemic anticoagulants (SA); However, the specific role of ACs in disease management remains unclear.
The association between in-hospital AC administration and survival was evaluated in a large cohort of hospitalized patients with COVID-19. This work was approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai (#20-03271).